|
|
|
|
| LEADER |
01000caa a22002652c 4500 |
| 001 |
NLM377415499 |
| 003 |
DE-627 |
| 005 |
20250306153039.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
240910s2024 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.3928/23258160-20240625-01
|2 doi
|
| 028 |
5 |
2 |
|a pubmed25n1257.xml
|
| 035 |
|
|
|a (DE-627)NLM377415499
|
| 035 |
|
|
|a (NLM)39254498
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Singh, Rishi P
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Development of a Consensus Guideline for the Diagnosis and Management of Chronic Noninfectious Uveitis Affecting the Posterior Segment
|
| 264 |
|
1 |
|c 2024
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 11.11.2024
|
| 500 |
|
|
|a Date Revised 22.11.2024
|
| 500 |
|
|
|a published: Print-Electronic
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 520 |
|
|
|a BACKGROUND AND OBJECTIVE: A consensus exercise was carried out to address unmet needs in the classification, diagnosis, and management of patients with chronic noninfectious uveitis affecting the posterior segment (NIU-PS), with a focus on chronic postoperative inflammation/cystoid macular edema
|
| 520 |
|
|
|a METHODS: Eight experts participated in roundtable discussions and consensus-building exercises to develop clear guidelines for the diagnosis and management of chronic NIU-PS. The group addressed questions surrounding clinical features, diagnostic tests, and treatment considerations
|
| 520 |
|
|
|a RESULTS: Clinicians agreed that chronic uveitis/intraocular inflammation should be defined as having persistence or recurrence for 3 or more months. Diagnosis is informed by evaluation of signs and symptoms, use of imaging, and exclusion of infectious etiologies. Management should be initiated with the least invasive therapies, proceeding to intraocular injections, and/or long-term intravitreal or systemic therapies, as necessary
|
| 520 |
|
|
|a CONCLUSION: This article offers an up-to-date consensus guideline based on clinical experience. Future clinical trials may help to test and reevaluate these recommendations. [Ophthalmic Surg Lasers Imaging Retina 2024;55:652-658.]
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Practice Guideline
|
| 700 |
1 |
|
|a Albini, Thomas A
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Baumal, Caroline R
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chang, Peter Y
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Eichenbaum, David
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Holekamp, Nancy
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Sharma, Sumit
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Singer, Michael
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Ophthalmic surgery, lasers & imaging retina
|d 2013
|g 55(2024), 11 vom: 01. Nov., Seite 652-658
|w (DE-627)NLM224956647
|x 2325-8179
|7 nnas
|
| 773 |
1 |
8 |
|g volume:55
|g year:2024
|g number:11
|g day:01
|g month:11
|g pages:652-658
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.3928/23258160-20240625-01
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_24
|
| 912 |
|
|
|a GBV_ILN_31
|
| 912 |
|
|
|a GBV_ILN_40
|
| 912 |
|
|
|a GBV_ILN_63
|
| 912 |
|
|
|a GBV_ILN_65
|
| 912 |
|
|
|a GBV_ILN_69
|
| 912 |
|
|
|a GBV_ILN_70
|
| 912 |
|
|
|a GBV_ILN_90
|
| 912 |
|
|
|a GBV_ILN_91
|
| 912 |
|
|
|a GBV_ILN_130
|
| 912 |
|
|
|a GBV_ILN_135
|
| 912 |
|
|
|a GBV_ILN_136
|
| 912 |
|
|
|a GBV_ILN_151
|
| 912 |
|
|
|a GBV_ILN_181
|
| 912 |
|
|
|a GBV_ILN_203
|
| 912 |
|
|
|a GBV_ILN_217
|
| 912 |
|
|
|a GBV_ILN_235
|
| 912 |
|
|
|a GBV_ILN_289
|
| 912 |
|
|
|a GBV_ILN_294
|
| 912 |
|
|
|a GBV_ILN_297
|
| 912 |
|
|
|a GBV_ILN_350
|
| 912 |
|
|
|a GBV_ILN_352
|
| 912 |
|
|
|a GBV_ILN_674
|
| 912 |
|
|
|a GBV_ILN_676
|
| 912 |
|
|
|a GBV_ILN_688
|
| 912 |
|
|
|a GBV_ILN_698
|
| 912 |
|
|
|a GBV_ILN_721
|
| 912 |
|
|
|a GBV_ILN_737
|
| 912 |
|
|
|a GBV_ILN_791
|
| 912 |
|
|
|a GBV_ILN_812
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 55
|j 2024
|e 11
|b 01
|c 11
|h 652-658
|